Editorial Type:
Article Category: Research Article
 | 
Online Publication Date: Dec 01, 2015

The Aeromedical Implications of Parkinson’s Disease

and
Page Range: 1046 – 1051
DOI: 10.3357/AMHP.4251.2015
Save
Download PDF

BACKGROUND: Parkinson’s disease is a progressive neurodegenerative disorder which is encountered in the pilot population and has clinical features that can impact on the flying role. This retrospective study reviewed the United Kingdom Civil Aviation Authority (UK CAA) experience of Parkinson’s disease. The aeromedical implications of the condition are discussed and the UK CAA policy for the certificatory assessment of pilots with Parkinson’s disease is described.METHODS: A search of the UK CAA medical records database from 1990 to 2015 identified 34 pilots with a diagnosis of Parkinson’s disease. Data was extracted for the class of medical certificate, time from first symptoms to diagnosis, age at diagnosis, the time from diagnosis to loss of certification and the reasons for loss of certification.RESULTS: Of 15 professional (Class 1) and 19 private (Class 2) pilots, the mean time from onset of symptoms to diagnosis was 36 and 19 mo, respectively. The mean ages at diagnosis were 55 and 59 yr, respectively. The mean interval from diagnosis to loss of certification was 21 (0-93) and 37 (0-84) mo, respectively. The reasons for loss of certification are considered.CONCLUSION: In the UK, pilots diagnosed with Parkinson’s disease may be granted medical certification depending on their functional ability and the side effect profile of medication. The aeromedical implications of Parkinson’s disease and the UK CAA policy for the certification of pilots with Parkinson’s disease are discussed.Jagathesan T, O’Brien MD. The aeromedical implications of Parkinson’s disease. Aerosp Med Hum Perform. 2015; 86(12):1046–1051.

  • Download PDF